1-193101163-G-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_197962.3(GLRX2):c.161C>A(p.Thr54Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000205 in 1,611,224 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_197962.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GLRX2 | NM_197962.3 | c.161C>A | p.Thr54Lys | missense_variant | 2/4 | ENST00000367439.8 | NP_932066.1 | |
GLRX2 | NM_016066.4 | c.164C>A | p.Thr55Lys | missense_variant | 2/4 | NP_057150.2 | ||
GLRX2 | NM_001243399.2 | c.41C>A | p.Thr14Lys | missense_variant | 2/4 | NP_001230328.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GLRX2 | ENST00000367439.8 | c.161C>A | p.Thr54Lys | missense_variant | 2/4 | 1 | NM_197962.3 | ENSP00000356409.3 | ||
GLRX2 | ENST00000367440.3 | c.164C>A | p.Thr55Lys | missense_variant | 2/4 | 1 | ENSP00000356410.3 | |||
GLRX2 | ENST00000472197.1 | n.482C>A | non_coding_transcript_exon_variant | 2/4 | 5 | |||||
GLRX2 | ENST00000608166.2 | n.161C>A | non_coding_transcript_exon_variant | 2/5 | 6 | ENSP00000494652.1 |
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 151990Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000716 AC: 18AN: 251358Hom.: 0 AF XY: 0.0000957 AC XY: 13AN XY: 135854
GnomAD4 exome AF: 0.0000219 AC: 32AN: 1459116Hom.: 0 Cov.: 28 AF XY: 0.0000358 AC XY: 26AN XY: 726088
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152108Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74328
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 20, 2021 | The c.164C>A (p.T55K) alteration is located in exon 2 (coding exon 2) of the GLRX2 gene. This alteration results from a C to A substitution at nucleotide position 164, causing the threonine (T) at amino acid position 55 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at